CAS 113975-22-7

Chemistry, 1 End Use API, 1 Related Intermediates

Manufacturers/Suppliers

1 Suppliers

1 Suppliers

Also known as: 113975-22-7, Pyridine, 2-fluoro-3-iodo-, 2-fluoro-3-iodo-pyridine, Mfcd03095287, 2-fluoro-3 iodopyridine, 2-fluoro-3-iodo-pyridin

Molecular Formula

C₅H₃FIN

Molecular Weight

222.99 g/mol

InChI Key

WCDCAXVNBOLWNO-UHFFFAOYSA-N

1 2D Structure

CAS 113975-22-7

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-fluoro-3-iodopyridine

2.1.2 InChI

InChI=1S/C5H3FIN/c6-5-4(7)2-1-3-8-5/h1-3H

2.1.3 InChI Key

WCDCAXVNBOLWNO-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1=CC(=C(N=C1)F)I

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 113975-22-7

2. Pyridine, 2-fluoro-3-iodo-

3. 2-fluoro-3-iodo-pyridine

4. Mfcd03095287

5. 2-fluoro-3 Iodopyridine

6. 2-fluoro-3-iodo-pyridin

7. 2- Fluoro-3-iodopyridine

8. Schembl320677

9. 2-fluoro-3-iodopyridine, 97%

10. Dtxsid60426560

11. Wcdcaxvnbolwno-uhfffaoysa-n

12. Cs-d0937

13. Akos005063878

14. Ab13652

15. Ac-3163

16. Ds-1318

17. Ps-7810

18. Sy004135

19. Am20050680

20. F0733

21. Ft-0601878

22. En300-83023

23. A803112

24. W-204827

25. Z1238548161

2.3 Create Date

2006-07-29

3 Chemical and Physical Properties

Molecular Formula	C₅H₃FIN
Molecular Weight	222.99 g/mol
XLogP3	1.9
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	2
Rotatable Bond Count	0
Exact Mass	g/mol
Monoisotopic Mass	g/mol
Topological Polar Surface Area	12.9
Heavy Atom Count	8
Formal Charge	0
Complexity	78.8
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Shenzhen HwaGen Pharmaceutical

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

(1R,2S,3S,4R)-ethyl 3-aminobicyclo[2.2.2]octane-2-carbo...

PDF Supplier PDF

URL Supplier Web Content

CAS Number

1626482-00-5

End Use API

Pimodivir

About the Company

Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leader...

Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leadership of a “National 1000 Talents Program” expert. By leveraging its core competency in chiral synthesis, enzymatic catalysis and continuous flow micro reactor, HwaGen Pharmaceutical is dedicated to development and manufacturing of specialty and niche intermediates and APIs covering various therapeutic areas including oncology, antiviral and respiratory, delivering high value-added and affordable products for global pharmaceutical industry. Equipments for Analysis & Test include Tabletop NMR, LC-MS, GC, HPLC etc.

ASK
US